MMP—9、TIMP—1对冠心病患者斑块稳定性的诊断价值探讨(2)
 |
| 第1页 |
参见附件。
[2] Jiang X， Zeng HS， Guo Y， et al. The expression of matrix metalloproteinases-9， transforming growth factor-β1 and transforming growth factor-β receptor Ⅰ in human atherosclerotic plaque and their relationship with plaque stability. Chinese Medical Journal， 2004， 117(12)： 1825-1829
[3] Gibbons RJ， Abrams J， Chatterjee K， et al. ACC/AHA 2002 Guideline Update for the Management of patients With chronic Stable Angina. Circulation， 2003， 107： 149-158.
[4] Califf HR， Phillips HR， Hindman MC. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol， 1985， 5： 1055～1063.
[5] Galis ZS ， Sukhova GK， Lark MW， et al. Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosc lerotic plaques. J Clin Invest 1994， 94(6)： 2493-2503
[6] Crisby M， Nordin-Frednksson G， Shah PK， et al. Pravastatin treatment increases collagen content and decreasea lipid content， inflammation， metalloproteinases， and cell death in human carotid plaquea： implications of plaque stabilization. Circulation， 2001， 103： 926-933
[7] Visse R， Hideaki N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure， function， and biochrmistry. CircRes， 2003， 92： 827-831
您现在查看是摘要介绍页，详见PDF附件。